Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Imidazoles/*therapeutic use"'
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 164
We saw a 59-year-old patient who was treated with dabrafenib and trametinib because of metastatic melanoma. She had an asymptomatic, black-blue macula in the excision scar. Histopathology showed tumoral melanosis. This is an histological term for der
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::1f1cbe6a328b41a927cc8376aa4a3a10
Publikováno v:
Nederlands tijdschrift voor geneeskunde, 164. Bohn Stafleu van Loghum
We saw a 59-year-old patient who was treated with dabrafenib and trametinib because of metastatic melanoma. She had an asymptomatic, black-blue macula in the excision scar. Histopathology showed tumoral melanosis. This is an histological term for der
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::a2973bdb6873a55dde1d4cfd4eba99d3
https://pure.amc.nl/en/publications/een-vrouw-met-een-voor-melanoom-verdachte-plek(fbdd369e-dcd2-45b3-b37a-60af20aa280f).html
https://pure.amc.nl/en/publications/een-vrouw-met-een-voor-melanoom-verdachte-plek(fbdd369e-dcd2-45b3-b37a-60af20aa280f).html
Autor:
Paul A. Baldock, Graham R. Williams, Babatunde O. Oyajobi, Alyson Morse, Anja Seckinger, Irene M. Ghobrial, Heather Fairfield, Lawrence M. T. Le, Tri Giang Phan, Peter I. Croucher, David G. Little, Tegan L. Cheng, Scott E. Youlten, David Abi-Hanna, Rachael L. Terry, Michaela Kneissel, Dirk Hose, Jessica A. Pettitt, Ina Kramer, Karin Vanderkerken, Michaela R. Reagan, Sindhu T. Mohanty, Carolyne Falank, Michelle M. McDonald, Marija K. Simic, J. H. Duncan Bassett
Multiple myeloma (MM) is a plasma cell cancer that develops in the skeleton causing profound bone destruction and fractures. The bone disease is mediated by increased osteoclastic bone resorption and suppressed bone formation. Bisphosphonates used fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de64ffc5e9c51813da549154b2c6cc9b
https://hdl.handle.net/20.500.14017/7adae6a1-cb61-4b8a-8c47-16347906c559
https://hdl.handle.net/20.500.14017/7adae6a1-cb61-4b8a-8c47-16347906c559
Autor:
Ezziat Sakina, Leonidas Zografos, Gürkan Kaya, Rosanna Pescini Gobert, Alexandre Moulin, Donata Rimoldi, Ikram El Zaoui, Serge Leyvraz, Carlo Rivolta, Michael Nicolas, Nicola Bedoni, Maya Bucher, Ann Schalenbourg, Nicolo Riggi
Publikováno v:
Investigative ophthalmology & visual science, vol. 60, no. 7, pp. 2764-2772
Investigative Ophthalmology & Visual Science, Vol. 60, No 7 (2019) pp. 2764-2772
Investigative Ophthalmology & Visual Science, Vol. 60, No 7 (2019) pp. 2764-2772
To analyze the activity of mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinases/mechanistic target of rapamycin (PI3K/mTOR) pathways in benign and malignant conjunctival melanocytic proliferations and explore whether specific inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f649a98d8f3cab0b5aed4aeee3cd1db2
https://doi.org/10.1167/iovs.18-26508
https://doi.org/10.1167/iovs.18-26508
Autor:
Alexandros D. Tselepis, C. Tzallas, C Petris, S.-A. Karabina, Elisaf, Eleni Bairaktari, Kostas C. Siamopoulos
Publikováno v:
Journal of Human Hypertension. 13:781-785
Moxonidine is a new antihypertensive agent whose mechanism of action appears to involve specific stimulation of imidazoline receptors resulting in an inhibition of the activity of the central and peripheral sympathetic nervous system. The drug seems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d67ee745df4917e16cd368e0135a0f4e
https://doi.org/10.1038/sj.jhh.1000835
https://doi.org/10.1038/sj.jhh.1000835
Publikováno v:
Søe, K, Delaissé, J-M, Jakobsen, E H, Hansen, C & Plesner, T 2014, ' Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer ', Acta Oncologica, vol. 53, no. 4, pp. 547-556 . https://doi.org/10.3109/0284186X.2013.844358
Zoledronic acid (Zol) is frequently used for the treatment of bone disease in patients with multiple myeloma and breast cancer with metastasis to bone. Therefore, there is also an interest in finding the optimal dosing regimen to optimize effects, mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807a3860da813696b8c4845c80cc1c2d
https://pubmed.ncbi.nlm.nih.gov/24164102
https://pubmed.ncbi.nlm.nih.gov/24164102
Paget's disease of bone is a focal skeletal disorder characterized by the formation of structurally abnormal bone, skeletal deformities, and other complications leading to bone pain and significant disability. It can involve one or more areas in a si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::82f7255439f81548a2470b947c70fca0
http://olympias.lib.uoi.gr/jspui/handle/123456789/24121
http://olympias.lib.uoi.gr/jspui/handle/123456789/24121
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
泌尿器科紀要. 13(9):703-707
Non-steroid anti-inflammatory drug, "Riripen" (Daiichi P h arm. Co.) was administered to patients with various urological diseases. The results are summarized as follows. 1. The drug was given to a total of 28 patients consisting of 16 with a cute cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::691fe43ab7f43c976c952a6b5316d307
http://hdl.handle.net/2433/113199
http://hdl.handle.net/2433/113199